BioSpace News Archive

Policy

Judge Orders Icahn to Strike Confidential Information from Illumina Lawsuit

Delaware Chancery Court Judge Paul Fioravanti on Tuesday ordered activist investor Carl Icahn to remove confidential information from his lawsuit against legacy Illumina board members.

January 17, 2024
·
2 min read
·
Tristan Manalac
Drug Development

Roche Reports Phase III TIGIT Win at ASCO Gastro Cancer Meeting

When combined with Tecentriq and chemotherapy, tiroagolumab increased median survival to 15.7 months compared to 11.1 months for patients with esophageal squamous cell carcinoma on chemo alone.

January 17, 2024
·
2 min read
·
Kate Goodwin
Drug Development

Optimistic, but for how long? Our big takeaways from #JPM2024

The team comes together to discuss the dominant themes of what was an incredibly busy week of events in San Francisco during JPM 2024.

January 17, 2024
·
1 min read
·
Lori Ellis
GSK Raises $1.24B by Selling Stake in Consumer Health Spin-Off Haleon

The British drugmaker on Wednesday said it sold around 300 million shares of Haleon, cutting its shareholding to 4.2%, as it expands its portfolio of specialty medicines, Reuters reported.

January 17, 2024
·
2 min read
·
Tristan Manalac
Job Trends

Top 5 Life Science Companies Hiring Remote

In a changing landscape, top companies are increasingly embracing remote work.

January 17, 2024
·
1 min read
·
Editorial Staff
FDA

Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder

The FDA on Tuesday extended the label for Takeda’s immune globulin infusion as a maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy.

January 17, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach

Then and Now: What’s Changed—and What Hasn’t—in Some Early Biopharma Hotbeds

People who worked in the industry around the time that BioSpace launched its Hotbeds Maps—including Marc Goldberg, a MassBio co-founder, and Biocom leader Joe Panetta—spoke with us about their experiences.

January 17, 2024
·
7 min read
·
Shawna Williams
Insilico CEO Alex Zhavoronkov Discusses AI Drug Discovery

The CEO of Insilico Medicine, which recently became the first company to launch Phase II trials for a drug developed using generative AI, spoke with BioSpace about the rise of the technology.

January 17, 2024
·
3 min read
·
Tyler Patchen
Policy

USPTO Rules Against Seagen in ADC Patent Battle with Daiichi Sankyo

The U.S. Patent and Trademark Office has sided with Daiichi over Seagen in a years-long patent saga concerning a key linker technology used in its blockbuster Enhertu antibody-drug conjugate for cancer.

January 17, 2024
·
2 min read
·
Tristan Manalac
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings

Pixium Vision SA announces that the decision of the Paris Commercial Court on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings has been postponed to a later date, which will be communicated by the Company as soon as it becomes aware of it.

January 17, 2024
·
1 min read